We previously observed increased ANGPTL4 serum levels in CHC patients without significant fibrosis before antiviral treatment23, indicating that ANGPTL4 expression levels are upregulated since early stages of chronic liver disease. The gene discussed is ANGPTL4; the disease is cryohydrocytosis.